Ritholtz Wealth Management Buys 42,553 Shares of Pediatrix Medical Group, Inc. $MD

Posted by on Jun 27th, 2026

Ritholtz Wealth Management boosted its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 42.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 143,668 shares of the company’s stock after purchasing an additional 42,553 shares during the period. Ritholtz Wealth Management’s holdings in Pediatrix Medical Group were worth $3,073,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of MD. Royal Bank of Canada increased its position in Pediatrix Medical Group by 23.8% in the first quarter. Royal Bank of Canada now owns 22,097 shares of the company’s stock worth $320,000 after buying an additional 4,247 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Pediatrix Medical Group by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 51,253 shares of the company’s stock worth $743,000 after buying an additional 2,251 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its position in shares of Pediatrix Medical Group by 4.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 268,506 shares of the company’s stock valued at $3,891,000 after buying an additional 12,171 shares in the last quarter. Cetera Investment Advisers purchased a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at about $145,000. Finally, Quantbot Technologies LP bought a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at approximately $99,000. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Performance

NYSE:MD opened at $24.60 on Friday. The stock has a 50-day moving average price of $22.89 and a 200 day moving average price of $21.75. The stock has a market capitalization of $2.02 billion, a P/E ratio of 11.94 and a beta of 0.69. Pediatrix Medical Group, Inc. has a 12-month low of $11.84 and a 12-month high of $24.99. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45.

Pediatrix Medical Group (NYSE:MD – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.44 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. Pediatrix Medical Group had a return on equity of 19.94% and a net margin of 9.02%.The company had revenue of $476.20 million for the quarter, compared to analysts’ expectations of $465.83 million. During the same period in the previous year, the firm earned $0.33 EPS. The firm’s revenue was up 3.9% compared to the same quarter last year. Equities research analysts forecast that Pediatrix Medical Group, Inc. will post 2.1 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on MD. Jefferies Financial Group reissued a “buy” rating and issued a $27.00 target price on shares of Pediatrix Medical Group in a report on Monday, April 20th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Wednesday. UBS Group upped their price target on shares of Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a research report on Tuesday, May 12th. Truist Financial increased their price objective on shares of Pediatrix Medical Group from $21.00 to $23.00 and gave the stock a “hold” rating in a research note on Monday, April 13th. Finally, Mizuho set a $24.00 price objective on shares of Pediatrix Medical Group in a research report on Friday, May 8th. One equities research analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, Pediatrix Medical Group has a consensus rating of “Hold” and an average target price of $22.50.

Read Our Latest Stock Report on MD

Insider Activity

In other news, Director Shirley A. Weis sold 36,028 shares of Pediatrix Medical Group stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total transaction of $855,665.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 1.80% of the stock is currently owned by insiders.

Pediatrix Medical Group Profile

(Free Report)

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.

Featured Stories

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.